Corporate and industrial form of the organization of health care

Abstract

In recent history, the functions and forms of health care remain insufficiently analyzed, despite the fact that the incentives invested in medicine determine not only the volume and structure of medical care, but also the reasons for its provision, which are becoming wider, and costs are increasing. The COVID-19 pandemic, as well as the global geopolitical, ideological and economic crisis that emerged in 2022, will require changes in both the structure and economics of the health care system in accordance with its main mission – providing conditions in which people can be healthy.The aim of this article is to analyze the concept of a modern health care system.Materials and methods. Statistical materials of the Russian Research Institute of Health, methods of content analysis, analytical materials of Russian and foreign researchers, including those posted on the Internet, were used.Results. The materials presented in the article allow us to talk about the emergence of a new form of healthcare organization during the life of just one generation of people, where economic incentives are dominant, characteristic of the market and commodity production, the vector of development of which is largely determined by the interests of international financial institutions, clinical corporations, as well as enterprises, manufacturing medical and pharmaceutical products. The expansion of the resource base in this model can occur by attributing epidemic character to certain diseases, as well as by turning social phenomena into medical problems. Therefore, there is always a shortage of resources, and it is not possible to eliminate it without changing the paradigm of the development of the industry and qualified management.Findings. Radical changes in the structure and economics of health care need to be made in line with the industry’s core mission of providing conditions in which people can stay healthy. The basis of these changes is the displacement of market self-regulation and the genesis of a mixed public-private (hybrid) healthcare economy.